Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Morphic Therapeutic
company
About
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies.
- 51 - 100
Details
- Last Funding Type
- Seed
- Last Funding Money Raised
- $3M
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Morphic Therapeutic is a biotechnology company developing a new generation of oral integrin therapies. Drawing on discoveries made in the lab of Scientific Founder Tim Springer, Morphic was created in 2015 with co-founders Polaris Partners, T.A. Springer and Schrödinger, Inc., along with ShangPharma Investment Group.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$134.50M
Morphic Therapeutic has raised a total of
$134.50M
in funding over 2 rounds. Their latest funding was raised on
Sep 25, 2018 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Sep 25, 2018 | Series B | $80M | 1 | — | — | Detail |
| Jun 30, 2016 | Series A | $51.50M | 1 | — | — | Detail |
| Jan 1, 2016 | Seed | $3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Morphic Therapeutic is funded by 1 investors.
Schrödinger
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Schrödinger
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
